...Click ...

The trial will enroll patients at four NABTT institutions; Wake Forest University, Emory University, University of Alabama at Birmingham and University of Pennsylvania. Up to 28 patients will be enrolled in this trial.

"Glioblastoma multiforme is an aggressive and fatal cancer with few treatment options, and we are anxious to evaluate this novel study drug in patients," said Dr. Kevin Judy of the University of Pennsylvania, the Neurosurgery Chair for the study....Click to read entire article...

Radio-guided Neurosurgery using a gamma probe for the treatment of brain cancer is the new technology developed by doctors at The Manipal Institute of Neurological Disorders at Manipal Hospital in Bangalore. The new technique effectively removes the brain tumor.

Removal of brain tumors surgically leads to enormous risks and the success of the tumor removal entirely depends on the surgeon’s skill. By using the new technology the effectiveness of tumor removal is highly successful.

The new procedure is done by inserting intravenously, an isotope called technetium-99m, which cruises on a molecule called Sestemabi, in the patient. The isotope then latches onto the cancerous tissue in the brain, making it glow like a light in the darkness. By using the glow caused by the gamma probe the brain tumor is detected and removed effectively.
...Click to read entire article...

CLICK HERE FOR ARTICLE"A compound
that kills cancer can sneak past the blood brain barrier to do its work in
fighting a particularly invasive brain cancer.

'The bottom line is, if you can get drugs into the brain, you can cure brain
cancer,' said Dr. William Banks of the St. Louis University School of Medicine.
The compound -- JV-1-36 -- is an antagonist of the hypothalamic growth hormone,
which has been found to cause cancerous tumors, such as malignant glioblastomas,
to grow.

Researchers found the blood brain barrier that usually keeps anti-cancer drugs
out of the brain, intercepted some of the JV-1-36 that was injected into mice,
but allowed much of it pass into the brain to treat cancer."